OpenAI Requests Congressional Guidance on Antitrust Issues Related to AI Development Slowdown

This inquiry could set a precedent for how AI companies collaborate on safety without breaching antitrust laws.

• On September 10, 2026, OpenAI sought guidance from U.S. lawmakers about the legality of coordinating a slowdown in AI development.
• Chief scientist Jakub Pachocki publicly advocated for voluntary slowdowns to establish safety standards amid rising concerns.
• A bipartisan bill aimed at allowing such coordination is currently stalled in the Judiciary Committee.

• Rapid AI development has been driven by intense competition between the U.S. and China, pushing labs to release models quickly without thorough risk assessments.
• Safety incidents at OpenAI and a petition signed by over 1,000 AI employees in July 2026 highlight the urgent need for a coordinated approach to AI safety.
• Antitrust implications arise because coordinated efforts to limit output could be interpreted as illegal under the Sherman Antitrust Act.

OpenAI's recent inquiries to Congress reflect a growing concern within the AI industry about balancing rapid innovation with safety. The company is navigating a complex landscape where the pressure to deliver cutting-edge technology competes with the need for responsible development. This tension is exacerbated by the competitive dynamics between major players in the AI sector, particularly in the context of U.S.-China rivalry.

The Sherman Antitrust Act prohibits agreements that restrain trade, which raises questions about whether AI labs can legally coordinate to slow down development for safety reasons. OpenAI's chief scientist, Jakub Pachocki, has publicly called for a voluntary slowdown until shared safety standards are established. This call is not just a response to internal pressures but also a reflection of broader industry sentiment, as evidenced by the July 2026 petition signed by over 1,000 AI employees advocating for mechanisms to slow development.

The bipartisan bill introduced in July 2026, known as the Collaboration on Adversarial Threats and Security Risks Act, aims to provide a legal framework for such coordination. However, it remains stalled in the Judiciary Committee, leaving companies like OpenAI in a legal gray area. The ongoing inquiries signal that OpenAI is seeking clarity on how to proceed without risking antitrust violations, which could deter collaboration on safety measures.

As the industry grapples with these challenges, the implications extend beyond legalities. If successful, this initiative could lead to the establishment of shared safety standards that would fundamentally reshape how AI is developed and deployed. It could also influence public perception of AI safety, potentially increasing trust among users and stakeholders. However, if the inquiries do not yield favorable outcomes, the pressure to innovate rapidly may continue to overshadow safety considerations, leading to further incidents and public backlash.

• AI Developers: They may face increased scrutiny and pressure to balance innovation with safety.
• Tech Companies: Firms involved in AI will need to navigate potential legal risks associated with coordinated efforts.
• Regulators: Government bodies will have to clarify antitrust laws as they pertain to emerging technologies.
• Consumers: Users of AI technologies may experience changes in product availability and safety standards.

• Legislative Movement: Keep an eye on the progress of the bipartisan bill in the Judiciary Committee, as its fate could influence industry practices.
• Industry Responses: Monitor how other AI companies react to OpenAI's inquiries and whether they initiate similar discussions with lawmakers.
• Public Safety Incidents: Watch for any new safety incidents in AI development that could reignite calls for regulation and oversight.